VE-cadherin expression in whole sections of CDX3 tumours was between 5–40% (determined by a Definiens algorithm) and co-localised with regions enriched for VM (defined by percentage of cells that were PAS+VE/CD31−VE; Fig. 4b). The gene discussed is CDH5; the disease is neoplasm.